May 13, 2019
Authored and Edited by Marcus A.R. Childress; Kevin D. Rodkey; Elizabeth D. Ferrill
In Trading Technologies International, Inc. v. IBG LLC, No. 2017-2323 (Fed. Cir. April 30, 2019), the Federal Circuit affirmed the Board’s decision, holding that Trading Technologies’ U.S. Patent No. 7,783,556 was eligible for CBM review and the challenged claims were not patent eligible under 35 U.S.C. § 101.
The ’556 patent relates to displaying market information on a screen and generating values that are derivatives of price, including profit and loss information, and then displaying these values along an axis on the display. IBG and others filed for CBM review of the ’556 patent. The Board issued a final written decision finding the challenged claims are not patent eligible under § 101. Trading Technologies appealed.
On appeal, the Federal Circuit agreed that the ’556 patent was eligible for CBM review. The Court explained that the challenged claims were directed to a “business problem” to provide traders additional information, such as profit and loss data, on an existing trading screen. The Court held that this was not a technological solution because it “improv[ed] the trader, not the functioning of the computer.”
The Court also affirmed the Board’s conclusion that the claims were directed to an unpatentable abstract idea of calculating and displaying information that “is nothing more than ‘mere automation of manual processes using computers.’” The Court also held that the claims failed to recite an inventive concept because the claimed trading screen simply took the prior art trading screen and added profit and loss values along the axis. Accordingly, the Court concluded the claims were ineligible under § 101.
Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.